Yu-Xuan Lyu
Corresponding/senior author of the same 2026 canine immune-aging and geroprotective-intervention study.
Institute of Advanced Biotechnology & Institute of Homeostatic Medicine, Southern University of Science and Technology, Shenzhen · Faculty of Medicine, Macau University of Science and Technology
Yu-Xuan Lyu is a corresponding author at the Institute of Advanced Biotechnology and Institute of Homeostatic Medicine at SUSTech in Shenzhen, with a joint appointment at the Faculty of Medicine, Macau University of Science and Technology. His group’s 2026 study found that canine immune aging is non-linear and sex-stratified, and that a 90-day course of rapamycin produced the broadest cytokine shift among three geroprotective interventions tested in young Beagles.
Milestones in the Atlas
A selection, not a full bibliography: only papers that meet the Atlas inclusion criteria.
| Year | Evidence | Study |
|---|---|---|
| 2026 | A | Sex-stratified immune patterns across the canine lifespan and short-term responses to geroprotective interventions LAI2026 Corresponding author on the canine rapamycin/canagliflozin/dietary-restriction immune-aging study. |
Co-authors in the Atlas
People with a profile here who share at least one study with Yu-Xuan Lyu.
- Meiling Lai First author of a 2026 study of immune aging across the canine lifespan and short-term responses to rapamycin.
Every researcher with a profile →
Thank you. Your answer was counted anonymously.
Thank you. That helps us know which pages have been read by someone who knows the work.
Thank you. We will check it and correct the page.